Professional Medical Expertise Company Income Statement

Financials in millions SAR. Fiscal year is January - December.

Millions SAR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	280.74	250.12	176.05	131.26	74.42
Revenue Growth (YoY)	27.02%	42.07%	34.12%	76.38%	-
Cost of Revenue	157.46	138.15	92.4	64.35	34.62
Gross Profit	123.28	111.96	83.65	66.91	39.8
Selling, General & Admin	81.12	75.83	55.24	42.02	27.65
Operating Expenses	84.98	78.62	57.64	42.46	28.15
Operating Income	38.3	33.34	26.01	24.45	11.65
Other Non Operating Income (Expenses)	-6.08	-6.13	-5.14	-2.64	-1.64
Pretax Income	30.33	27.22	20.87	21.81	10
Income Tax Expense	2.54	2.37	1.85	1.19	0.71
Earnings From Continuing Operations	27.79	24.84	19.02	20.62	9.3
Minority Interest in Earnings	0	-0	-	-	-
Net Income	27.79	24.84	19.02	20.62	9.3
Net Income to Common	27.79	24.84	19.02	20.62	9.3
Net Income Growth	20.84%	30.65%	-7.78%	121.80%	-
Shares Outstanding (Basic)	4	4	2	1	-
Shares Outstanding (Diluted)	4	4	2	1	-
Shares Change (YoY)	-0.40%	56.73%	189.51%	-	-
EPS (Basic)	7.94	7.10	8.52	26.73	-
EPS (Diluted)	7.94	7.10	8.52	26.73	-
EPS Growth	21.32%	-16.64%	-68.15%	-	-
Free Cash Flow	-5.58	-3.1	-10.43	17.69	9.93
Free Cash Flow Per Share	-1.59	-0.89	-4.67	22.93	-
Gross Margin	43.91%	44.76%	47.51%	50.98%	53.48%
Operating Margin	13.64%	13.33%	14.77%	18.63%	15.65%
Profit Margin	9.90%	9.93%	10.80%	15.71%	12.49%
Free Cash Flow Margin	-1.99%	-1.24%	-5.93%	13.48%	13.35%
EBITDA	42.8	37.34	28.07	26.25	13.26
EBITDA Margin	15.25%	14.93%	15.94%	20.00%	17.82%
D&A For EBITDA	4.5	3.99	2.06	1.79	1.62
EBIT	38.3	33.34	26.01	24.45	11.65
EBIT Margin	13.64%	13.33%	14.77%	18.63%	15.65%
Effective Tax Rate	8.37%	8.72%	8.88%	5.46%	7.07%

Source: S&P Capital IQ. Standard template. Financial Sources.